Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$10.8 - $17.94 $546,717 - $908,158
-50,622 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$10.92 - $18.18 $430,007 - $715,892
-39,378 Reduced 43.75%
50,622 $913,000
Q2 2018

Aug 14, 2018

BUY
$10.0 - $17.87 $900,000 - $1.61 Million
90,000 New
90,000 $1.36 Million

Others Institutions Holding OBSV

About ObsEva SA


  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.